Author:
Myo Melissa,Heyrana Katrina J.,Nguyen Brian T.
Publisher
Springer International Publishing
Reference45 articles.
1. ACOG. Long-acting reversible contraception: implants and intrauterine devices. Pract Bull. 2017; 186. https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2017/11/long-acting-reversible-contraception-implants-and-intrauterine-devices
2. ACOG. Over-the-counter access to hormonal contraception | ACOG. ACOG Committee Opinion; 2019. p. 788. https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2019/10/over-the-counter-access-to-hormonal-contraception
3. Ali M, Akin A, Bahamondes L, Brache V, Habib N, Landoulsi S, Hubacher D. Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant. Hum Reprod. 2016;31(11):2491–8. https://doi.org/10.1093/HUMREP/DEW222.
4. Allen D, Hunter MS, Wood S, Beeson T. One key question ®: first things first in reproductive health. Matern Child Health J. 2017;21(3):387–92. https://doi.org/10.1007/S10995-017-2283-2.
5. Audet MC, Moreau M, Koltun WD, Waldbaum AS, Shangold G, Fisher AC, Creasy GW. Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial. JAMA. 2001;285(18):2347–54. https://doi.org/10.1001/JAMA.285.18.2347.